PharmaShots | Incisive News in 3 Shots

Subscribe Now

Four-Week Dosing Schedule

BMS' Opdivo (nivolumab) Receives CHMP Recommendation for Approval of its Four-Week Dosing Schedule

BMS' Opdivo (nivolumab) Receives CHMP Recommendation for Approval of its Four-Week Dosing Schedule

September 24, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us